Correction to Abbott Beats Forecasts Article
16 July 2020 - 10:52PM
Dow Jones News
Abbott Laboratories' second-quarter revenue from diagnostics
climbed to $1.99 billion, with U.S. diagnostics sales rising 23% to
$857 million in the quarter. "Abbott Beats Forecasts on Strong
Covid-19 Testing Business," published at 7:49 a.m., misstated total
diagnostics revenue rose 23% to $857 million.
(END) Dow Jones Newswires
July 16, 2020 08:37 ET (12:37 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
From Apr 2024 to May 2024
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
From May 2023 to May 2024